HomeXBRANE • STO
add
Xbrane Biopharma AB
Previous close
kr 10.53
Day range
kr 10.25 - kr 10.89
Year range
kr 9.86 - kr 38.25
Market cap
215.12M SEK
Avg Volume
235.85K
P/E ratio
1.03
Dividend yield
-
Primary exchange
STO
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 10.12M | -37.49% |
Operating expense | 19.67M | 16.50% |
Net income | -24.03M | 46.74% |
Net profit margin | -237.47 | 14.80% |
Earnings per share | -1.17 | 68.16% |
EBITDA | -21.87M | -52.97% |
Effective tax rate | -0.03% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 93.56M | 205.85% |
Total assets | 701.48M | -16.46% |
Total liabilities | 114.43M | -80.25% |
Total equity | 587.05M | — |
Shares outstanding | 20.61M | — |
Price to book | 0.37 | — |
Return on assets | -9.46% | — |
Return on capital | -12.43% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -24.03M | 46.74% |
Cash from operations | -49.43M | -231.73% |
Cash from investing | -66.46M | -178.09% |
Cash from financing | 206.00M | 6,553.63% |
Net change in cash | 86.43M | 304.59% |
Free cash flow | -109.99M | -529.25% |
About
CEO
Founded
2008
Website
Employees
26
